MetLife Investment Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.36M Buy
131,954
+1,932
+1% +$63.8K 0.03% 635
2025
Q1
$5.23M Sell
130,022
-3,680
-3% -$148K 0.03% 588
2024
Q4
$6.29M Buy
133,702
+10,394
+8% +$489K 0.03% 440
2024
Q3
$6.51M Buy
123,308
+538
+0.4% +$28.4K 0.04% 399
2024
Q2
$6.65M Buy
122,770
+22,222
+22% +$1.2M 0.04% 361
2024
Q1
$7.05M Buy
100,548
+51,460
+105% +$3.61M 0.05% 336
2023
Q4
$4.1M Hold
49,088
0.03% 593
2023
Q3
$1.45M Hold
49,088
0.01% 1048
2023
Q2
$1.6M Buy
49,088
+6,111
+14% +$199K 0.01% 1026
2023
Q1
$1.51M Hold
42,977
0.01% 1013
2022
Q4
$1.97M Hold
42,977
0.01% 906
2022
Q3
$2.08M Buy
42,977
+333
+0.8% +$16.1K 0.02% 857
2022
Q2
$1.68M Buy
42,644
+52
+0.1% +$2.04K 0.01% 961
2022
Q1
$1.57M Buy
42,592
+13,764
+48% +$507K 0.01% 1094
2021
Q4
$1.31M Hold
28,828
0.01% 1019
2021
Q3
$1.03M Buy
28,828
+3,351
+13% +$120K 0.01% 1107
2021
Q2
$504K Hold
25,477
﹤0.01% 1563
2021
Q1
$593K Sell
25,477
-2,978
-10% -$69.3K 0.01% 1426
2020
Q4
$591K Hold
28,455
0.01% 1401
2020
Q3
$616K Buy
28,455
+2,107
+8% +$45.6K 0.01% 1261
2020
Q2
$621K Hold
26,348
0.01% 1260
2020
Q1
$311K Hold
26,348
﹤0.01% 1465
2019
Q4
$280K Hold
26,348
﹤0.01% 1794
2019
Q3
$300K Hold
26,348
﹤0.01% 1708
2019
Q2
$296K Buy
26,348
+7,632
+41% +$85.9K ﹤0.01% 1794
2019
Q1
$151K Hold
18,716
﹤0.01% 2132
2018
Q4
$118K Hold
18,716
﹤0.01% 2213
2018
Q3
$184K Hold
18,716
﹤0.01% 2135
2018
Q2
$155K Hold
18,716
﹤0.01% 2032
2018
Q1
$135K Hold
18,716
﹤0.01% 2084
2017
Q4
$153K Buy
+18,716
New +$153K ﹤0.01% 2058